Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Gains from Investment Securities (2021 - 2026)

MoonLake Immunotherapeutics' Gains from Investment Securities history spans 6 years, with the latest figure at -$422000.0 for Q1 2026.

  • Quarterly Gains from Investment Securities fell 240.32% to -$422000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $289000.0 through Mar 2026, up 180.58% year-over-year, with the annual reading at $587000.0 for FY2025, 158.59% up from the prior year.
  • Gains from Investment Securities came in at -$422000.0 for Q1 2026, down from $587000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $3.7 million in Q4 2023 to a low of -$1.2 million in Q3 2025.
  • The 5-year median for Gains from Investment Securities is $1277.0 (2022), against an average of $318928.9.
  • The largest YoY upside for Gains from Investment Securities was 769.47% in 2023 against a maximum downside of 1902.28% in 2023.
  • MoonLake Immunotherapeutics' Gains from Investment Securities stood at $429501.0 in 2022, then skyrocketed by 769.47% to $3.7 million in 2023, then crashed by 93.92% to $227000.0 in 2024, then surged by 158.59% to $587000.0 in 2025, then tumbled by 171.89% to -$422000.0 in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Gains from Investment Securities are -$422000.0 (Q1 2026), $587000.0 (Q4 2025), and -$1.2 million (Q3 2025).